These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

389 related items for PubMed ID: 21310852

  • 1. Growth hormone signaling in human T47D breast cancer cells: potential role for a growth hormone receptor-prolactin receptor complex.
    Xu J, Zhang Y, Berry PA, Jiang J, Lobie PE, Langenheim JF, Chen WY, Frank SJ.
    Mol Endocrinol; 2011 Apr; 25(4):597-610. PubMed ID: 21310852
    [Abstract] [Full Text] [Related]

  • 2. The role of prolactin receptor in GH signaling in breast cancer cells.
    Xu J, Sun D, Jiang J, Deng L, Zhang Y, Yu H, Bahl D, Langenheim JF, Chen WY, Fuchs SY, Frank SJ.
    Mol Endocrinol; 2013 Feb; 27(2):266-79. PubMed ID: 23192981
    [Abstract] [Full Text] [Related]

  • 3. Growth hormone (GH) receptor (GHR)-specific inhibition of GH-Induced signaling by soluble IGF-1 receptor (sol IGF-1R).
    Zhang Y, Gc S, Patel SB, Liu Y, Paterson AJ, Kappes JC, Jiang J, Frank SJ.
    Mol Cell Endocrinol; 2019 Jul 15; 492():110445. PubMed ID: 31100495
    [Abstract] [Full Text] [Related]

  • 4. GHR/PRLR Heteromultimer Is Composed of GHR Homodimers and PRLR Homodimers.
    Liu Y, Zhang Y, Jiang J, Lobie PE, Paulmurugan R, Langenheim JF, Chen WY, Zinn KR, Frank SJ.
    Mol Endocrinol; 2016 May 15; 30(5):504-17. PubMed ID: 27003442
    [Abstract] [Full Text] [Related]

  • 5. Development of a novel ligand that activates JAK2/STAT5 signaling through a heterodimer of prolactin receptor and growth hormone receptor.
    Langenheim JF, Chen WY.
    J Recept Signal Transduct Res; 2009 May 15; 29(2):107-12. PubMed ID: 19519175
    [Abstract] [Full Text] [Related]

  • 6. Activation of growth hormone receptors by growth hormone and growth hormone antagonist dimers: insights into receptor triggering.
    Yang N, Langenheim JF, Wang X, Jiang J, Chen WY, Frank SJ.
    Mol Endocrinol; 2008 Apr 15; 22(4):978-88. PubMed ID: 18096690
    [Abstract] [Full Text] [Related]

  • 7. Two wrongs can make a right: dimers of prolactin and growth hormone receptor antagonists behave as agonists.
    Langenheim JF, Tan D, Walker AM, Chen WY.
    Mol Endocrinol; 2006 Mar 15; 20(3):661-74. PubMed ID: 16269515
    [Abstract] [Full Text] [Related]

  • 8. Subdomain 2, Not the Transmembrane Domain, Determines the Dimerization Partner of Growth Hormone Receptor and Prolactin Receptor.
    Liu Y, Jiang J, Lepik B, Zhang Y, Zinn KR, Frank SJ.
    Endocrinology; 2017 Oct 01; 158(10):3235-3248. PubMed ID: 28977606
    [Abstract] [Full Text] [Related]

  • 9. Inhibition of oncogene STAT3 phosphorylation by a prolactin antagonist, hPRL-G129R, in T-47D human breast cancer cells.
    Cataldo L, Chen NY, Yuan Q, Li W, Ramamoorthy P, Wagner TE, Sticca RP, Chen WY.
    Int J Oncol; 2000 Dec 01; 17(6):1179-85. PubMed ID: 11078803
    [Abstract] [Full Text] [Related]

  • 10. A conformationally sensitive GHR [growth hormone (GH) receptor] antibody: impact on GH signaling and GHR proteolysis.
    Jiang J, Wang X, He K, Li X, Chen C, Sayeski PP, Waters MJ, Frank SJ.
    Mol Endocrinol; 2004 Dec 01; 18(12):2981-96. PubMed ID: 15345746
    [Abstract] [Full Text] [Related]

  • 11. The role of prolactin and growth hormone in breast cancer.
    Wennbo H, Törnell J.
    Oncogene; 2000 Feb 21; 19(8):1072-6. PubMed ID: 10713692
    [Abstract] [Full Text] [Related]

  • 12. Growth hormone and prolactin receptors in adipogenesis: STAT-5 activation, suppressors of cytokine signaling, and regulation of insulin-like growth factor I.
    Fleenor D, Arumugam R, Freemark M.
    Horm Res; 2006 Feb 21; 66(3):101-10. PubMed ID: 16735796
    [Abstract] [Full Text] [Related]

  • 13. A Novel Mechanism of hPRL-G129R, a Prolactin Antagonist, Inhibits Human Breast Cancer Cell Proliferation and Migration.
    Li R, Yang Y, Lan H, Wang Y, Ge Z, Liu X, Zhou Y, Zhang W, Xian L, Yuan H.
    Endocrinology; 2023 Nov 02; 164(12):. PubMed ID: 37934803
    [Abstract] [Full Text] [Related]

  • 14. Evolution of the receptors for growth hormone, prolactin, erythropoietin and thrombopoietin in relation to the vertebrate tetraploidizations.
    Ocampo Daza D, Larhammar D.
    Gen Comp Endocrinol; 2018 Feb 01; 257():143-160. PubMed ID: 28652136
    [Abstract] [Full Text] [Related]

  • 15. Prolactin, growth hormone, and epidermal growth factor activate Stat5 in different compartments of mammary tissue and exert different and overlapping developmental effects.
    Gallego MI, Binart N, Robinson GW, Okagaki R, Coschigano KT, Perry J, Kopchick JJ, Oka T, Kelly PA, Hennighausen L.
    Dev Biol; 2001 Jan 01; 229(1):163-75. PubMed ID: 11133161
    [Abstract] [Full Text] [Related]

  • 16. Diphenylbutylpiperidine Antipsychotic Drugs Inhibit Prolactin Receptor Signaling to Reduce Growth of Pancreatic Ductal Adenocarcinoma in Mice.
    Dandawate P, Kaushik G, Ghosh C, Standing D, Ali Sayed AA, Choudhury S, Subramaniam D, Manzardo A, Banerjee T, Santra S, Ramamoorthy P, Butler M, Padhye SB, Baranda J, Kasi A, Sun W, Tawfik O, Coppola D, Malafa M, Umar S, Soares MJ, Saha S, Weir SJ, Dhar A, Jensen RA, Thomas SM, Anant S.
    Gastroenterology; 2020 Apr 01; 158(5):1433-1449.e27. PubMed ID: 31786131
    [Abstract] [Full Text] [Related]

  • 17. Prolactin induces up-regulation of its cognate receptor in breast cancer cells via transcriptional activation of its generic promoter by cross-talk between ERα and STAT5.
    Kavarthapu R, Tsai Morris CH, Dufau ML.
    Oncotarget; 2014 Oct 15; 5(19):9079-91. PubMed ID: 25193864
    [Abstract] [Full Text] [Related]

  • 18. Dynamic responses of prolactin, growth hormone and their receptors to hyposmotic acclimation in the olive flounder Paralichthys olivaceus.
    Yuan M, Jia Q, Wang T, Lu Q, Tang L, Wang Y, Lu W.
    Gen Comp Endocrinol; 2017 Dec 01; 254():8-13. PubMed ID: 28927875
    [Abstract] [Full Text] [Related]

  • 19. Human metastatic melanoma cell lines express high levels of growth hormone receptor and respond to GH treatment.
    Sustarsic EG, Junnila RK, Kopchick JJ.
    Biochem Biophys Res Commun; 2013 Nov 08; 441(1):144-50. PubMed ID: 24134847
    [Abstract] [Full Text] [Related]

  • 20. Prolactin Signaling Stimulates Invasion via Na(+)/H(+) Exchanger NHE1 in T47D Human Breast Cancer Cells.
    Pedraz-Cuesta E, Fredsted J, Jensen HH, Bornebusch A, Nejsum LN, Kragelund BB, Pedersen SF.
    Mol Endocrinol; 2016 Jul 08; 30(7):693-708. PubMed ID: 27176613
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.